Matches in Wikidata for { <http://www.wikidata.org/entity/Q91964470> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q91964470 description "article scientifique publié en 2020" @default.
- Q91964470 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q91964470 description "im April 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91964470 description "scientific article published on 14 April 2020" @default.
- Q91964470 description "wetenschappelijk artikel" @default.
- Q91964470 description "наукова стаття, опублікована 14 квітня 2020" @default.
- Q91964470 name "Improved Dissolution and Pharmacokinetics of Abiraterone through KinetiSol® Enabled Amorphous Solid Dispersions" @default.
- Q91964470 name "Improved Dissolution and Pharmacokinetics of Abiraterone through KinetiSol® Enabled Amorphous Solid Dispersions" @default.
- Q91964470 type Item @default.
- Q91964470 label "Improved Dissolution and Pharmacokinetics of Abiraterone through KinetiSol® Enabled Amorphous Solid Dispersions" @default.
- Q91964470 label "Improved Dissolution and Pharmacokinetics of Abiraterone through KinetiSol® Enabled Amorphous Solid Dispersions" @default.
- Q91964470 prefLabel "Improved Dissolution and Pharmacokinetics of Abiraterone through KinetiSol® Enabled Amorphous Solid Dispersions" @default.
- Q91964470 prefLabel "Improved Dissolution and Pharmacokinetics of Abiraterone through KinetiSol® Enabled Amorphous Solid Dispersions" @default.
- Q91964470 P1433 Q91964470-31C27177-9BA1-4A8A-915F-02BADCB0404D @default.
- Q91964470 P1476 Q91964470-1F71B5D7-E3D0-4634-ACA0-BCC4B099E4A4 @default.
- Q91964470 P2093 Q91964470-19D7719E-472B-435B-8D24-B949373761B4 @default.
- Q91964470 P2093 Q91964470-2C31CEAF-7A6A-4B6F-87B0-22313025A96F @default.
- Q91964470 P275 Q91964470-f3889994-9cee-4921-8d2c-03f4e5e22278 @default.
- Q91964470 P31 Q91964470-6D7BA57B-1A97-4F5D-A6B1-1EAAF0038588 @default.
- Q91964470 P356 Q91964470-723DFDB0-3D2C-4BA7-97C2-126D3CDA752A @default.
- Q91964470 P433 Q91964470-D0930CA9-1DE1-4C10-A8A2-E9B464745D63 @default.
- Q91964470 P478 Q91964470-C9421CB7-807B-4F1C-9EBA-44A0A6E15EAD @default.
- Q91964470 P50 Q91964470-BDAD24D7-DABB-47C2-ACC7-E6735ABBF00B @default.
- Q91964470 P577 Q91964470-6864DB71-C523-4045-8DA9-ECBB1B8787AA @default.
- Q91964470 P6216 Q91964470-5857c8c2-5304-4316-a347-495c05b543de @default.
- Q91964470 P698 Q91964470-68DCF3F8-8CA1-4B36-9D03-899523556A62 @default.
- Q91964470 P921 Q91964470-F18DEC7B-9FF0-43E9-BD4D-CD757CCE73FF @default.
- Q91964470 P932 Q91964470-2134A5B1-7FFD-48C7-B28C-A10E0A8D60EB @default.
- Q91964470 P356 PHARMACEUTICS12040357 @default.
- Q91964470 P698 32295245 @default.
- Q91964470 P1433 Q27723332 @default.
- Q91964470 P1476 "Improved Dissolution and Pharmacokinetics of Abiraterone through KinetiSol® Enabled Amorphous Solid Dispersions" @default.
- Q91964470 P2093 "Dave Miller" @default.
- Q91964470 P2093 "Robert O Williams" @default.
- Q91964470 P275 Q20007257 @default.
- Q91964470 P31 Q13442814 @default.
- Q91964470 P356 "10.3390/PHARMACEUTICS12040357" @default.
- Q91964470 P433 "4" @default.
- Q91964470 P478 "12" @default.
- Q91964470 P50 Q91964468 @default.
- Q91964470 P577 "2020-04-14T00:00:00Z" @default.
- Q91964470 P6216 Q50423863 @default.
- Q91964470 P698 "32295245" @default.
- Q91964470 P921 Q323936 @default.
- Q91964470 P932 "7238130" @default.